/PRNewswire/ The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and.
Results from the first session of Late-Breaking Clinical Trials were presented on Oct. 31 during The VEINS conference, hosted in Las Vegas, NV, announced by the VIVA Foundation.
/PRNewswire/ The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and.